Long term genitourinary toxicity following curative intent intensity-modulated radiotherapy for prostate cancer: a systematic review and meta-analysis
R David, A Buckby, AA Kahokehr, J Lee… - Prostate Cancer and …, 2023 - nature.com
Background Recent studies have shown that radiation-induced pelvic toxicity often requires
urological consultation. However, the 10-year incidence of genitourinary toxicity following …
urological consultation. However, the 10-year incidence of genitourinary toxicity following …
Mucoadhesive chitosan-pectinate nanoparticles for the delivery of curcumin to the colon
In the present study, we report the properties of a mucoadhesive chitosan-pectinate
nanoparticulate formulation able to retain its integrity in the milieu of the upper …
nanoparticulate formulation able to retain its integrity in the milieu of the upper …
[PDF][PDF] RETRACTED ARTICLE: Novel purine thioglycoside analogs: synthesis, nanoformulation and biological evaluation in in vitro human liver and breast cancer …
MA Abu-Zaied, SA Loutfy, AE Hassan… - Drug Design …, 2019 - Taylor & Francis
Abu-Zaied MA, Loutfy SA, Hassan AE, Elgemeie GH. Drug Des Devel Ther. 2019; 13: 2437–
2457. The Editor and Publisher of Drug Design, Development and Therapy wish to retract …
2457. The Editor and Publisher of Drug Design, Development and Therapy wish to retract …
Is modern external beam radiotherapy with androgen deprivation therapy still a viable alternative for prostate cancer in an era of robotic surgery and brachytherapy: A …
Introduction We compare the results of modern external‐beam radiotherapy (EBRT), using
combined androgen deprivation and dose‐escalated intensity‐modulated radiotherapy with …
combined androgen deprivation and dose‐escalated intensity‐modulated radiotherapy with …
Synergistic locoregional chemoradiotherapy using a composite liposome-in-gel system as an injectable drug depot
S GuhaSarkar, K Pathak, N Sudhalkar… - International Journal …, 2016 - Taylor & Francis
The use of radiosensitizers in clinical radiotherapy is limited by systemic toxicity. The
biopolymeric, biodegradable, injectable liposome-in-gel-paclitaxel (LG-PTX) system was …
biopolymeric, biodegradable, injectable liposome-in-gel-paclitaxel (LG-PTX) system was …
Ten-year outcomes of intensity-modulated radiation therapy combined with neoadjuvant hormonal therapy for intermediate-and high-risk patients with T1c-T2N0M0 …
T Mizowaki, Y Norihisa, K Takayama, I Ikeda… - International journal of …, 2016 - Springer
Background We aimed to analyze the 10-year outcomes of intensity-modulated radiation
therapy (IMRT) combined with neoadjuvant hormonal therapy (HT) for patients with …
therapy (IMRT) combined with neoadjuvant hormonal therapy (HT) for patients with …
Prostate cancer intensity-modulated radiotherapy and long term genitourinary toxicity: An evolving therapeutic landscape
“Long Term Genitourinary Toxicity following Curative Intent Intensity-Modulated
Radiotherapy for Prostate Cancer: A Systematic Review and Meta-analysis” by David R et …
Radiotherapy for Prostate Cancer: A Systematic Review and Meta-analysis” by David R et …
Radical radiotherapy for high-risk prostate cancer in older men
HA Payne, S Hughes - The Oncologist, 2012 - academic.oup.com
Historical data for older men with high-risk nonmetastatic prostate cancer treated with
radiotherapy alone have demonstrated a 10-year prostate-cancer-specific mortality of …
radiotherapy alone have demonstrated a 10-year prostate-cancer-specific mortality of …
78Gy with Fiducial Marker Image‐Guided Radiotherapy in Prostate Cancer: Single Center Analysis of 301 Patients
ES Choong, G Hruby, J Yang, C Kwong… - Asia‐Pacific Journal …, 2017 - Wiley Online Library
Aim In prostate cancer, fiducial marker image‐guided radiotherapy (FMIGRT) allows
correction of setup errors and interfraction physiological motion resulting in improved …
correction of setup errors and interfraction physiological motion resulting in improved …
[PDF][PDF] THESIS/THÈSE
S DABO - 2024 - pure.unamur.be
La radiothérapie est une technique utilisée pour traiter plus de la moitié des patients atteints
de cancer. Cependant, malgré son amélioration par la radiothérapie avec modulation …
de cancer. Cependant, malgré son amélioration par la radiothérapie avec modulation …